Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8716 |
High Similarity |
NPD6674 |
Discontinued |
0.8681 |
High Similarity |
NPD1613 |
Approved |
0.8681 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.858 |
High Similarity |
NPD7228 |
Approved |
0.8491 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8472 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8408 |
Intermediate Similarity |
NPD37 |
Approved |
0.8403 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8387 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8365 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8365 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8365 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8253 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8193 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8163 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.816 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.8151 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8144 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8095 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8084 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8047 |
Intermediate Similarity |
NPD7240 |
Approved |
0.8024 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7988 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7974 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7952 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7917 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7914 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7895 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7895 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.784 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7836 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7793 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7791 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7682 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.768 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7679 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7679 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7671 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7661 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD7680 |
Approved |
0.76 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7582 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7568 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7557 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7544 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7515 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7443 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7443 |
Intermediate Similarity |
NPD8312 |
Approved |
0.743 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7401 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7391 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7374 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7374 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7374 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7374 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7348 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7321 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7318 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7308 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7308 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7308 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7303 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7301 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7297 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7297 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7296 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7296 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7283 |
Intermediate Similarity |
NPD27 |
Approved |
0.7283 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7278 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7278 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7267 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7262 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7256 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7251 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7247 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7247 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7239 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7239 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7239 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7232 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.723 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7225 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7225 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7219 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7215 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7215 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7212 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7191 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7171 |
Intermediate Similarity |
NPD8651 |
Approved |
0.716 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7153 |
Intermediate Similarity |
NPD228 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7135 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7126 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7125 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7117 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7115 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7111 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7105 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7075 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7074 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7074 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7074 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7074 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7074 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7074 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7074 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7069 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7059 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7025 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7018 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7018 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7013 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7012 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6993 |
Remote Similarity |
NPD5327 |
Phase 3 |
0.6993 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6989 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6986 |
Remote Similarity |
NPD7843 |
Approved |
0.6982 |
Remote Similarity |
NPD4675 |
Approved |
0.6982 |
Remote Similarity |
NPD4678 |
Approved |
0.6975 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6975 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6975 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD422 |
Phase 1 |
0.6966 |
Remote Similarity |
NPD8156 |
Discontinued |
0.6963 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6959 |
Remote Similarity |
NPD6671 |
Approved |
0.6957 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD4666 |
Phase 3 |
0.6951 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6948 |
Remote Similarity |
NPD6696 |
Suspended |
0.6944 |
Remote Similarity |
NPD2684 |
Approved |
0.6943 |
Remote Similarity |
NPD7095 |
Approved |
0.6941 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD4055 |
Discovery |
0.6933 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD7041 |
Phase 2 |
0.6928 |
Remote Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.6923
|
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |